DUBLIN, Oct. 12, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/q3msrx/european_enzyme) has announced the addition of the "European Enzyme Immunoassay (EIA) Market By Type, By Technique, By End User (Hospital Laboratories, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Reference Laboratories, Academics, Blood Banks) Analysis and Forecast to 2020" report to their offering.
The report analyzes the European enzyme immunoassay (EIA) Market by type, technique, end-user, and by country. The European enzyme immunoassay (EIA) market has been classified on the basis of types which mainly includes; EIA reagents & kits, and EIA analyzers. On the basis of technique the market is divided into; ELISA, rapid tests, and ELISPOT.
Germany is the largest contributor to the European enzyme immunoassay (EIA) market, basically due to the rising incidences of chronic and infectious diseases, expanding pharmaceutical and biotechnology industries, and growing use of EIA in oncology. Germany is followed by U.K., and France.
Enzyme immunoassays are widely used in the diagnosis of and research of HIV/AIDS and cancer, owing to which the increasing prevalence of HIV/AIDS and cancer in Europe will drive market growth in the region. According to WHO, the number of HIV patients in Europe increased from 120,000 in 2011 to 180,000 in 2012. Furthermore, according to the International Agency for Research on Cancer (IARC), approximately 3.45 million new cancer cases (excluding non-melanoma skin cancer) were reported in Europe in 2012; the prevalence is expected to grow further in the coming years.
In-depth Market share analysis, by revenue, of the top companies is also included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, Annual reports and interviews with industry experts, key opinion leaders such as CEOs, directors, and marketing executives. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company.
Some of the key market players of the European enzyme immunoassay (EIA) market include Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), bioMérieux SA (France), Siemens Healthcare GmbH (Germany), Alere (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.) and others.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Market Overview
5 Europe Enzyme Immunoassay (EIA) Market, Type/Technique
6 Europe Enzyme Immunoassay (EIA) Market, By End-User
7 Europe Enzyme Immunoassay (EIA) Market, By Geography
8 Europe Enzyme Immunoassay (EIA) Market: Competitive Landscape
9 Europe Enzyme Immuno Assay (EIA) Market, By Company
- Abbott Laboratories, Inc. - Alere, Inc. - Beckman Coulter (Subsidiary Of Danaher Corporation) - Becton, Dickinson And Company - Bio-Rad Laboratories, Inc. - Biomérieux Sa - Diasorin S.P.A. - Ortho-Clinical Diagnostics, Inc. - Roche Diagnostics (A Division Of F. Hoffmann-La Roche Ltd.) - Siemens Healthcare (Subsidiary Of Siemens Ag) - Sysmex Corporation
For more information visit http://www.researchandmarkets.com/research/q3msrx/european_enzyme
Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets